“Benefits of Semaglutide on Chronic Kidney Disease Outcomes by Cardiovascular Status of Risk in the FLOW Trial."

Publication Title

AHA Scientific Sessions 2024

Document Type

Abstract

Publication Date

11-1-2024

Keywords

spokane; pmrc; washington

Area of Special Interest

Kidney & Diabetes

Specialty/Research Institute

Endocrinology

Specialty/Research Institute

Nephrology

This document is currently not available here.


Share

COinS